Two months of the most targeted joint support Vetoquinol makes for dogs. Flexadin® Advanced with Boswellia (60 count) pairs UC-II® Undenatured Type II Collagen — clinically proven to surpass glucosamine and chondroitin — with Boswellia serrata, the anti-inflammatory botanical that works on the same inflammatory pathways as prescription NSAIDs, without the associated side-effect risks.
The UC-II mechanism: When joints degrade, damaged collagen fragments trigger an autoimmune attack on healthy cartilage — accelerating the very damage causing pain. UC-II, taken orally, reaches the gut-associated lymphoid tissue and activates T-regulatory cells that shut down this cycle. It's a fundamentally different approach to joint protection than supplementing building blocks.
The Boswellia advantage: Boswellic acids specifically inhibit 5-lipoxygenase (5-LOX), the enzyme at the heart of joint inflammation. Unlike general COX inhibitors (NSAIDs), they spare the gut lining — making Boswellia a valuable tool for dogs who can't tolerate prescription anti-inflammatories.
One chew daily. Any size dog. No weight-based dosing. No loading phase. 60 chews means consistent, uninterrupted joint support for two full months — which is when the most significant cumulative benefits tend to appear.
Vetoquinol — 85+ years of veterinary pharmaceutical research. Vet-exclusive. Clinically validated.